CEVA INC (CEVA) Stock Fundamental Analysis
NASDAQ:CEVA - Nasdaq - US1572101053 - Common Stock - Currency: USD
Overall CEVA gets a fundamental rating of 4 out of 10. We evaluated CEVA against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CEVA as it has an excellent financial health rating, but there are worries on the profitability. CEVA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CEVA was profitable.
In the past year CEVA had a positive cash flow from operations.
CEVA had negative earnings in 4 of the past 5 years.
CEVA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.84%, CEVA is doing worse than 62.96% of the companies in the same industry.
With a Return On Equity value of -3.30%, CEVA is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.84% | ||
| ROE | -3.3% | ||
| ROIC | N/A |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 88.06%, CEVA belongs to the top of the industry, outperforming 99.07% of the companies in the same industry.
In the last couple of years the Gross Margin of CEVA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 88.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CEVA has more shares outstanding
The number of shares outstanding for CEVA has been increased compared to 5 years ago.
There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CEVA has an Altman-Z score of 11.97. This indicates that CEVA is financially healthy and has little risk of bankruptcy at the moment.
CEVA has a better Altman-Z score (11.97) than 84.26% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 11.97 |
ROIC/WACCN/A
WACC11.16%
2.3 Liquidity
CEVA has a Current Ratio of 7.09. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
CEVA has a better Current ratio (7.09) than 90.74% of its industry peers.
CEVA has a Quick Ratio of 7.09. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CEVA (7.09) is better than 95.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.09 | ||
| Quick Ratio | 7.09 |
3. Growth
3.1 Past
CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 270.00%, which is quite impressive.
Measured over the past years, CEVA shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.60% on average per year.
The Revenue has grown by 9.77% in the past year. This is quite good.
The Revenue has been growing slightly by 4.17% on average over the past years.
EPS 1Y (TTM)270%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%10%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%20.95%
3.2 Future
Based on estimates for the next years, CEVA will show a very strong growth in Earnings Per Share. The EPS will grow by 42.97% on average per year.
The Revenue is expected to grow by 12.05% on average over the next years. This is quite good.
EPS Next Y45.01%
EPS Next 2Y58.39%
EPS Next 3Y42.97%
EPS Next 5YN/A
Revenue Next Year10.73%
Revenue Next 2Y11.93%
Revenue Next 3Y12.05%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 87.65, the valuation of CEVA can be described as expensive.
CEVA's Price/Earnings ratio is in line with the industry average.
CEVA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
CEVA is valuated quite expensively with a Price/Forward Earnings ratio of 60.45.
Based on the Price/Forward Earnings ratio, CEVA is valued a bit more expensive than the industry average as 60.19% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CEVA is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.65 | ||
| Fwd PE | 60.45 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CEVA does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CEVA's earnings are expected to grow with 42.97% in the coming years.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y58.39%
EPS Next 3Y42.97%
5. Dividend
5.1 Amount
CEVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
32.43
+0.21 (+0.65%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners89.78%
Inst Owner Change-0.66%
Ins Owners2.67%
Ins Owner Change14.3%
Market Cap772.16M
Analysts81.67
Price Target37.91 (16.9%)
Short Float %5%
Short Ratio3.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.53%
Min EPS beat(2)-0.15%
Max EPS beat(2)41.21%
EPS beat(4)2
Avg EPS beat(4)91.73%
Min EPS beat(4)-288.54%
Max EPS beat(4)614.39%
EPS beat(8)3
Avg EPS beat(8)20.56%
EPS beat(12)6
Avg EPS beat(12)16.9%
EPS beat(16)9
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)1.65%
Min Revenue beat(2)-0.66%
Max Revenue beat(2)3.96%
Revenue beat(4)2
Avg Revenue beat(4)2.68%
Min Revenue beat(4)-6.45%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.18%
Revenue beat(12)4
Avg Revenue beat(12)-6.13%
Revenue beat(16)8
Avg Revenue beat(16)-2.94%
PT rev (1m)10.95%
PT rev (3m)13.2%
EPS NQ rev (1m)-14.63%
EPS NQ rev (3m)-14.63%
EPS NY rev (1m)-4.01%
EPS NY rev (3m)-4.01%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)1.5%
Revenue NY rev (3m)1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.65 | ||
| Fwd PE | 60.45 | ||
| P/S | 7.22 | ||
| P/FCF | N/A | ||
| P/OCF | 222.46 | ||
| P/B | 2.9 | ||
| P/tB | 3.74 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.37
EY1.14%
EPS(NY)0.54
Fwd EY1.65%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.15
OCFY0.45%
SpS4.49
BVpS11.2
TBVpS8.67
PEG (NY)1.95
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.84% | ||
| ROE | -3.3% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 88.06% | ||
| FCFM | N/A |
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.65% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.09 | ||
| Quick Ratio | 7.09 | ||
| Altman-Z | 11.97 |
F-Score7
WACC11.16%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)270%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%10%
EPS Next Y45.01%
EPS Next 2Y58.39%
EPS Next 3Y42.97%
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%20.95%
Revenue Next Year10.73%
Revenue Next 2Y11.93%
Revenue Next 3Y12.05%
Revenue Next 5YN/A
EBIT growth 1Y43.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y154.82%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%